Kletzer Joseph, Buechner Wanda, Czerny Martin, Gottardi Roman, Berger Tim, Dimov Aleksandar, Lescan Mario, Kreibich Maximilian, Kondov Stoyan
Department of Cardiovascular Surgery, University Hospital Freiburg Heart Centre, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.
BMC Cardiovasc Disord. 2025 Jun 2;25(1):426. doi: 10.1186/s12872-025-04851-0.
Aim of this study was to assess geometrical changes of implanted Dacron grafts following open surgical ascending aortic replacement.
Geometrical Dacron graft changes were analysed during the postoperative follow-up of 215 who received ascending aortic surgery between 02/2010 and 12/2020. Data was analysed using a linear mixed effects model over long-term follow-up.
One-hundred forty-five (67%) patients of our cohort were male, with a median age of 61 years 52-71.5). Most patients had a history of hypertension (79%). Proximal diameter of the implanted grafts grew at a rate of 0.251 cm (0.181-0.328 cm; p < 0.001) per year. In contrast, distal diameter stayed constant over time (0.019 cm; -0.048-0.135 cm; p = 0.366), while prosthesis length measured at the centreline decreased at a rate of -0.835 cm (-0.969 cm - -0.581 cm; p < 0.001) per year.
In contrast to the native aorta, Dacron grafts seem to decrease in length over time. At the same time, there is a significant increase in proximal diameter. The specific dimensional changes, and differences to the nominal graft dimensions, should be considered at the time of graft implantation to ensure a durable platform for secondary aortic interventions.
Not applicable. IRB: 04/02/2021 (No. 20-1302).
本研究旨在评估开放手术升主动脉置换术后植入的涤纶人工血管的几何形状变化。
对2010年2月至2020年12月期间接受升主动脉手术的215例患者进行术后随访,分析涤纶人工血管的几何形状变化。在长期随访中使用线性混合效应模型分析数据。
我们队列中的145例(67%)患者为男性,中位年龄为61岁(52 - 71.5岁)。大多数患者有高血压病史(79%)。植入人工血管的近端直径以每年0.251 cm(0.181 - 0.328 cm;p < 0.001)的速度增长。相比之下,远端直径随时间保持不变(0.019 cm;-0.048 - 0.135 cm;p = 0.366),而中心线处测量的人工血管长度以每年-0.835 cm(-0.969 cm - -0.581 cm;p < 0.001)的速度下降。
与天然主动脉不同,涤纶人工血管的长度似乎会随时间减少。同时,近端直径有显著增加。在植入人工血管时应考虑特定的尺寸变化以及与标称人工血管尺寸的差异,以确保为二次主动脉干预提供持久的平台。
不适用。机构审查委员会:2021年4月2日(编号20 - 1302)。